Health
NewsOnScale Staff
October 7, 2026
The United States declared measles eradicated in 2000. In 2026, it recorded its worst measles outbreak in 35 years — more than 2,300 confirmed cases across 44 states, driven almost entirely by declining vaccination rates.
The outbreak is a symptom. The disease is something else.
For decades, Americans have watched a healthcare system that charges more than any other country in the developed world and delivers middling outcomes. The US spends roughly $4.5 trillion annually on healthcare. Life expectancy is lower than in peer nations. Maternal mortality is higher. Chronic disease rates — obesity, diabetes, heart disease — have climbed despite billions spent treating them. Drug prices are set not by what they cost to make but by what the market will bear.
The incentive structure is worth understanding. A patient who is cured is no longer a customer. A patient managed with ongoing prescriptions, regular office visits, and periodic procedures is revenue. That is not a conspiracy theory. It is the documented business model of a fee-for-service healthcare system that profits from treatment rather than outcomes.
RFK Jr., Trump's Health Secretary, has spent years arguing that vaccines are unsafe and that health authorities cannot be trusted. He arrived in office as measles cases were already climbing. Whether his public platform accelerated vaccine hesitancy or simply reflected it, the result is the same: Americans — particularly parents — are declining vaccines for their children at rates not seen in decades.
The trust problem is real. Doctors and hospitals are not a monolith of corruption, and many deliver genuine care. But the system around them creates pressures that don't always serve patients. Pharmaceutical companies have paid billions in fines for misleading marketing. Insurance companies deny coverage as a business strategy. Hospital billing is deliberately opaque.
When people lose trust in institutions, they don't lose it selectively. The parent who distrusts pharmaceutical companies also distrusts the MMR vaccine. The patient who watched a family member go through chemotherapy that extended life by months at enormous cost and suffering is skeptical of the next treatment recommendation.
That skepticism is understandable. The consequences of it — measles outbreaks, declining childhood vaccination rates, the return of diseases that were eliminated — fall hardest on children too young to make their own choices.
The story of 2026 is not that measles is back. It is that enough Americans distrust the system that produced the measles vaccine that they are willing to risk a disease that killed hundreds of American children every year before that vaccine existed.
That is what a broken relationship between medicine and the public looks like.
NewsOnScale is owned by AMILLI AI, Corp., founded by JJ Johnson.